Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Oct 21, 2014 2:58pm
140 Views
Post# 23048158

RE:RE:RE:Merck

RE:RE:RE:MerckCasusF, You wrote: Has any of the research determined this to be an issue? Has Theralase published anything or made statements concluding that PDC uptake into tumors is not 100%. Where did this idea come from? Well, it might have come from the fact that TLT has done trials on 5mm tumors in mice! As someone mathematically went thru for you the other day, if you have a 10mm tumor and assuming it to be roughly cylindrical then the mass of the 10mm tumor is 8 times that of the 5mm (you'll recall from high school math that 2 dimensional objects are squared and 3 dimensional objects are cubed so to illustrate further, a 40mm tumor is 64 times the size of the 5mm one). Let's hope that there is complete dispersion of PDC but TLT has also spoken to dispersion in their trials. The idea of validating this in a large mammal while awaiting Ph1/2a results makes perfect sense. Try to keep up!
Bullboard Posts